Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
Launched by ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Sep 25, 2008
Trial Information
Current as of June 08, 2025
Recruiting
Keywords
ClinConnect Summary
**Trial Summary: Establishment of a Lifetime Cohort of Adults Surviving Childhood Cancer**
This clinical trial, called SJLIFE, aims to study the long-term health of adults who were treated for childhood cancer at St. Jude Children's Research Hospital. Researchers want to understand how childhood cancer treatment may lead to health issues later in life, even many years after treatment has ended. By gathering information from these survivors, the study will help identify factors that contribute to health problems and possibly develop better ways to monitor and protect against these issues as they age.
To participate, individuals must be at least five years post-diagnosis of a childhood cancer and treated at St. Jude. They should also be willing to be part of the study and follow the hospital's guidelines. The study is currently recruiting participants, including those who have survived childhood cancer and a control group of individuals without a history of childhood cancer. Participants can expect to share their health history and may provide samples for future research. This study is important because it will help improve the care and support for those who have battled childhood cancer and are now navigating their adult lives.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient will have a diagnosis of childhood malignancy (or neoplasm requiring similar therapy) that was treated or followed at St. Jude Children's Research Hospital.
- • Patient will be at least five years from diagnosis.
- • Patient is willing to participate at any level of study
- • Patient is willing to comply with the guidelines of St. Jude domiciliary care facilities
- • Patient or legally authorized representative must sign informed consent for study participation.
- Control Participant:
- • ≥5 years of age
- • Non-first degree relatives or friends of St. Jude patients or former patients or SJCRH employees/affiliates who are not SJLIFE study team members, or family members of SJLIFE study team, or supervised by a SJLIFE study team members, or any volunteer not associated with St. Jude.
- • Participant does not have a diagnosis of childhood malignancy or childhood neoplasm requiring similar therapy (i.e., diagnosed \<21 years of age).
- • Participant is not currently pregnant or lactating.
- • Patient is willing to comply with the guidelines of St. Jude domiciliary care facilities.
- • Patient must sign informed consent for study participation.
- Exclusion Criteria:
- • Patient or control subject refuses to participate at any level of study
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier pediatric research institution dedicated to advancing the treatment and understanding of catastrophic diseases in children, particularly cancer and other life-threatening conditions. Renowned for its innovative clinical trials and cutting-edge research, St. Jude integrates patient care with scientific discovery to develop new therapies and improve outcomes for young patients. The hospital is committed to ensuring that no family receives a bill for treatment, travel, housing, or food, fostering a holistic approach to pediatric care. Through collaboration with global research networks, St. Jude aims to share its findings and expertise to enhance treatment options worldwide, making significant strides in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
Melissa Hudson, MD
Principal Investigator
St. Jude Children's Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials